Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

scPharmaceuticals Inc. - Common Stock (NQ: SCPH )

3.680 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about scPharmaceuticals Inc. - Common Stock

< Previous 1 2 3 Next >
5 Analysts Have This to Say About scPharmaceuticals
Via Benzinga
$5 Million Bet On Lifecore Biomedical? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed mostly lower on Tuesday, there were a few notable insider trades. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Analyst Ratings for scPharmaceuticals
Within the last quarter, scPharmaceuticals (NASDAQ:SCPH) has observed the following analyst ratings: 
Via Benzinga
Expert Ratings for scPharmaceuticals
Analysts have provided the following ratings for scPharmaceuticals (NASDAQ:SCPH) within the last quarter: 
Via Benzinga
Short Volatility Alert: AscPharmaceuticals Inc.
On Wednesday, shares of scPharmaceuticals Inc. (NASDAQ: SCPH) experienced volatile short activity. After the activity, the stock price went up +1.75% to $5.70. The overall sentiment for SCPH has been... 
Via Benzinga
FDA Approves scPharmaceuticals' Self-Administered Med For Congestion in Chronic Heart Failure
Via Benzinga
Recap: scPharmaceuticals Q1 Earnings
scPharmaceuticals (NASDAQ:SCPH) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday. 
Via Benzinga
US Stocks Open Lower, Dow Falls 100 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Tuesday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
Upgrades 
Via Benzinga
Alphabet To $134? Plus This Analyst Slashes Price Target On McDonald's
Credit Suisse cut the price target on Alphabet Inc. (NASDAQ: GOOGL) from $140 to $134. Credit Suisse analyst Stephen Ju maintained an Outperform rating on the stock. Alphabet shares fell 1.2% to $96.69... 
Via Benzinga
Bilibili, H World Group And Other Big Losers From Monday
U.S. stocks closed lower with the Nasdaq Composite dropping more than 100 points on Monday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Dow Rises 30 Points; Crude Oil Down 2%
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 30 points on Monday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers 
Via Benzinga
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued... 
Via Benzinga
Wall Street Pulls Back As Chip Stocks Dent Nasdaq
Falling semiconductor stocks are weighing on the Nasdaq Composite (IXIC) this afternoon, with the tech-laden benchmark hitting its lowest level since September 2020. 
Via Talk Markets
Why Is ACM Research (ACMR) Stock Down 26% Today?
ACM Research (ACMR) stock is taking a beating on Monday after the U.S. placed restrictions on exports of certain chip technology. 
Via InvestorPlace
Why Is Applied DNA (APDN) Stock Up 70% Today?
Applied DNA (APDN) stock is rocketing higher on Monday after the company announced a massive order for its LinearDNA product. 
Via InvestorPlace
Nasdaq Dips 150 Points; Gold Down 2%
U.S. stocks pared gains midway through trading, with the Dow Jones dropping more than 100 points on Monday. 
Via Benzinga
Why Is scPharmaceuticals (SCPH) Stock in the Spotlight Today?
It's a good-news, bad-news situation for SCPH stock today, but mostly bad news as scPharmaceuticals agrees to take on high-interest debt. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers NeuroMetrix (NASDAQ:NURO) shares increased by 23.0% to $3.48 during Monday's pre-market session. The company's market cap stands at $24.8 million. 
Via Benzinga
Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the... 
Via Benzinga
Why Myovant Sciences Is Trading Higher By Over 26%; Here Are 31 Stocks Moving Premarket
Gainers Wearable Devices Ltd. (NASDAQ: WLDS) rose 58% to $1.39 in pre-market trading after declining around 8% on Friday. Wearable Devices, last week, posted a 1H loss of $0.18 per share. 
Via Benzinga
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
Upgrades 
Via Benzinga
scPharmaceuticals Shares Are Trading High Following FDA's Acceptance of NDA for FUROSCIX
scPharmaceuticals Inc. (NASDAQ: SCPH) announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) of the drug candidate FUROSCIX, for the treatment of... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE: 
Via Benzinga
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.